Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea
Authors:
- Jin Seok KimJKJin Seok Kim
- Jun Ho JangJJJun Ho Jang
- Deog-Yeon JoDJDeog-Yeon Jo
- Seo-Yeon AhnSASeo-Yeon Ahn
- Sung-Soo YoonSYSung-Soo Yoon
- Je-Hwan LeeJLJe-Hwan Lee
- Sung-Hyun KimSKSung-Hyun Kim
- Chul Won ChoiCCChul Won Choi
- Ho-Jin ShinHSHo-Jin Shin
- Min-Kyoung KimMKMin-Kyoung Kim
- Jae Hoon LeeJLJae Hoon Lee
- Yeung-Chul MunYMYeung-Chul Mun
Open Access
- 1 January 2023
- journal article
- research article
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (41) , e328
Abstract
Kim JS, et al. J Korean Med Sci. 2023 Sep;38:e328. https://doi.org/10.3346/jkms.2023.38.e328Keywords
Funding Information
- Handok Inc
This publication has 14 references indexed in Scilit:
- High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal VaccineMMWR. Morbidity and Mortality Weekly Report, 2017
- Paroxysmal nocturnal haemoglobinuriaNature Reviews Disease Primers, 2017
- Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohortBlood Research, 2017
- Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in JapanInternational Journal of Hematology, 2016
- Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH RegistryJournal of Korean Medical Science, 2016
- Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no‐treatment studyAmerican Journal of Hematology, 2015
- Paroxysmal nocturnal hemoglobinuriaBlood, 2014
- Predictors of hemoglobin response to eculizumab therapy in paroxysmal nocturnal hemoglobinuriaEuropean Journal of Haematology, 2012
- Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survivalBlood, 2011
- Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.Journal of Clinical Investigation, 1989